Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Immunotherapy firm OncoResponse secures $40m series B financing
Image: OncoResponse will use funding to advance its five drug candidates into preclinical and clinical development. Photo: courtesy of cooldesign / FreeDigitalPhotos.net.
Image: OncoResponse will use funding to advance its five drug candidates into preclinical and clinical development. Photo: courtesy of cooldesign / FreeDigitalPhotos.net.